# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Malignant mesenchymal tumor

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 51-60 of 516 results.
Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)
Status: Available
Last Changed: Jun 25, 2019
First Received: Apr 10, 2018
Disease(s): Uterine Sarcoma
Intervention(s): Everolimus
National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group
Status: Recruiting
Last Changed: Jul 02, 2019
First Received: Jun 06, 2019
Disease(s): Sarcoma
Intervention(s): Chemotherapy, Immunotherapeutic Agent, target treatment, Surgery, Radiotherapy
Locations: Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France
Centre Léon Bérard, Lyon, France
Institut Gustave Roussy, Comprehensive Cancer Center, Villejuif, France
Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma
Status: Recruiting
Last Changed: Jan 03, 2019
First Received: Jan 03, 2019
Disease(s): Retroperitoneal Sarcoma
Intervention(s): Doxorubicin
Locations: National Cancer Centre Singapore, Singapore, Singapore
Circulating Tumor DNA in Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Oct 28, 2019
First Received: Jan 28, 2019
Disease(s): Soft Tissue Sarcoma
Intervention(s): Archival tumor tissue collection and blood draws
Locations: Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma
Status: Recruiting
Last Changed: Sep 26, 2019
First Received: Apr 17, 2017
Disease(s): Soft Tissue Sarcoma
Intervention(s): Combination Radiation, Immunotherapy, Surgery
Locations: University of Maryland Medical Center, Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States
An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)
Status: Recruiting
Last Changed: Mar 21, 2019
First Received: May 17, 2017
Disease(s): Kaposi Sarcoma, HIV Infections
Intervention(s): Tc99m-tilmanocept
Locations: Zuckerberg San Francisco General Hospital, San Francisco, California, United States
Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Mar 21, 2019
First Received: Mar 19, 2019
Disease(s): Sarcoma
Intervention(s): Anlotinib+ Liposomal Doxorubicin
Locations: Peking University Shougang Hospital, Beijing, Beijing, China
Beijing Cancer Hospital, Beijing, Beijing, China
Peking University People's Hospital, Beijing, Beijing, China
Hunan Cancer Hospital, Changsha, Hunan, China
First Hospital of Jilin University, Chang chun, Jilin, China
... and 4 other locations.
Repeat or Single Quadratus Lumborum Block for the Reduction of Opioid Prescriptions After Surgery in Retroperitoneal Sarcoma Patients ("RESQU-SARC" Trial)
Status: Not yet recruiting
Last Changed: Dec 06, 2019
First Received: Dec 06, 2019
Disease(s): Retroperitoneal Sarcoma
Intervention(s): Liposomal Bupivacaine, Quadratus Lumborum Block, Questionnaire Administration
Locations: M D Anderson Cancer Center, Houston, Texas, United States
Registry of Retroperitoneal, Abdominal, Pelvic and Truncal Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet® to Evaluate the Safety and Feasibility Over 5 Years
Status: Not yet recruiting
Last Changed: Jul 25, 2019
First Received: Jul 25, 2019
Disease(s): Sarcoma
Intervention(s): CivaSheet
Locations: Rush University Cancer Center, Chicago, Illinois, United States
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
A Study of NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma
Status: Recruiting
Last Changed: Feb 17, 2020
First Received: Sep 13, 2017
Disease(s): SARCOMA
Intervention(s): NKTR-214, Nivolumab
Locations: Memorial Sloan Kettering Cancer Center (only recruiting to the Vascular/Angiosarcoma cohort), New York, New York, United States
MD Anderson Cancer Center (only recruiting to the Vascular/Angiosarcoma cohort), Houston, Texas, United States